|Year : 2017 | Volume
| Issue : 2 | Page : 99-106
Prevalence and determinants of tobacco consumption among pregnant women of three Central Indian Districts
Priti Verma1, Pavan Pandey2, Avinash Thakur3
1 Department of Obstetrics and Gynecology, Ram Krishna Dharmarth Foundation Medical College, Bhopal, Madhya Pradesh, India
2 Program Officer, Jhpiego, Bhopal, Madhya Pradesh, India
3 Department of Forensic Medicine and Toxicology, Gandhi Medical College, Bhopal, Madhya Pradesh, India
|Date of Web Publication||21-Aug-2017|
E-33 Surya Apartments, Model Town, Nehru Nagar (E), Bhilai - 490 020, Chhattisgarh
Source of Support: None, Conflict of Interest: None
Background: About 6.8% of Indian women consume tobacco and only 21.0% receive 'full' antenatal care. Thus, there are chances that women who consume tobacco during the non-pregnant state will continue to use tobacco during pregnancy.
Materials and Methods: A cross-sectional study was conducted across nine health centres in three districts of Madhya Pradesh, India. A total of 3,839 women admitted in the post-partum ward of selected hospitals were interviewed about tobacco consumption during pregnancy. Adjusted odds ratios were calculated to determine the predictors of tobacco consumption during pregnancy.
Results: The prevalence of tobacco consumption during pregnancy was 13.1%. Only 4.4% of women who consumed tobacco and 1.6% of women who did not use tobacco were advised against tobacco consumption by frontline health workers. The strongest predictors of tobacco consumption were tobacco consumption by husband [AOR = 36.16 (CI = 22.89–68.86)], neighbor/female friend consuming tobacco [AOR = 22.29 (CI = 13.11–31.82)], and female family members consuming tobacco [AOR = 5.63 (CI = 4.39–7.53)].
Conclusion: Awareness among women about adverse effects of tobacco consumption during pregnancy was low. Health system intervention in the form of health education and advice against tobacco consumption was virtually non-existent.
Keywords: India; pregnancy; tobacco; women
|How to cite this article:|
Verma P, Pandey P, Thakur A. Prevalence and determinants of tobacco consumption among pregnant women of three Central Indian Districts. Trop J Obstet Gynaecol 2017;34:99-106
|How to cite this URL:|
Verma P, Pandey P, Thakur A. Prevalence and determinants of tobacco consumption among pregnant women of three Central Indian Districts. Trop J Obstet Gynaecol [serial online] 2017 [cited 2020 Feb 29];34:99-106. Available from: http://www.tjogonline.com/text.asp?2017/34/2/99/213448
| Introduction|| |
Seven decades after independence, India has not been able to provide 'full' antenatal care to every pregnant woman. Overall only, 21.0% (urban = 31.1%, rural = 16.7%) women in India received 'full' antenatal care. In the state of Madhya Pradesh, only half (53.1%) of all pregnant women visited health centres during the first trimester, only one-third (35.7%) had four antenatal visits and merely 11.4% received 'full' antenatal care. Tobacco use during pregnancy can contribute to maternal and perinatal/infant mortality.,,,,, Pregnant women who consume tobacco are at an increased risk of developing life-threating complications such as placenta praevia, placental abruption and pre-eclampsia., However, more severe and permanent are the detrimental effects of tobacco on the fetus, which include low birth weight, premature birth, intrauterine growth restriction and an overall increase in perinatal/infant mortality.,,, As per the National Family Health Survey (NFHS)-4, the prevalence of tobacco consumption among Indian women was 6.8% (urban = 4.4%, rural = 8.1%). As per NFHS-3, about 9.5% of all pregnant women (smokeless tobacco = 8.5%, smoking = 1.0%) in India consumed tobacco in one form or another.
With such low level of antenatal care coverage, there are good chances that some women might consume inappropriate stuff such as teratogenic medicines, tobacco, alcohol or other harmful substances during pregnancy. There can be multiple reasons for such undesired health behaviour including lack of intervention (s) by the health system.,, Many pregnant women, especially those who are less educated might not be aware of the harmful effects of tobacco consumption during pregnancy, thus it is the responsibility of health system to intervene by educating and advising them against tobacco consumption. Guidelines prescribed by the government of India for antenatal care and Indian Public Health Standards (IPHS) clearly mention that auxiliary nurse midwife (ANM) and physician should ask a pregnant woman about tobacco consumption habit/history during antenatal visits and intervene by advising pregnant women to give up tobacco at least during pregnancy and possibly forever.,
In the absence of recent population-based estimates about the tobacco use during pregnancy, we do not know whether there is a need for tobacco cessation program specifically for pregnant women, and for those who are planning to conceive in the near future. Moreover, we do not have any idea about the extent of knowledge a pregnant woman has about harmful effects of tobacco use during pregnancy. Lastly, we do not have any data to support whether the auxiliary nurse midwives (ANMs), ASHA (community health worker) and physicians currently provide any type of health education to pregnant women against tobacco use during pregnancy. Thus, to fill the existing gap in knowledge, we undertook this study with the objective to assess the prevalence, extent and determinants of tobacco use during the pregnancy.
| Materials and Methods|| |
This was a hospital-based cross-sectional study. The total duration of the study was 11 months, from March 2016 to January 2017. The period of data collection was 6 months (June 2016 to December 2016). The study was conducted at multiple government hospitals where women come for antenatal care and childbirth. The present study was conducted in three districts of Madhya Pradesh, India. Indian health system is organised as a three-tier system. The primary level is constituted by the primary health centre (PHC) and health sub-centre (HSC). Secondary level is constituted by community health centre (CHC), sub-district hospital and district hospital. Tertiary level is constituted by medical colleges and sub-specialties hospitals. Facilities for antenatal care and child-birth are available at all level of health facilities.
The study employed two-stage sampling. In the first stage, one block was selected from each district using simple random sampling technique. In the second stage, 1 community health centre and 2 primary health centres were randomly selected from each pre-selected block. In this manner, we selected 3 community health centres and 6 primary health centres for recruiting study participants. Women of all ages and parity coming for labor at selected hospitals.
Exclusion criteria included (1) any women (pregnant or post-partum) or her newborn that had to be referred out to the higher facility for any complications and (2) women who did not give consent for the study.
Participant's recruitments: As per the Janani Sishu Suraksha Karyakram (JSSK), all women who come for labour at public health facility stay at a health facility for 48 hours after delivery. JSSK entitles pregnant women coming for child-birth at public health facilities to absolutely free and no expense delivery including caesarian section. This scheme stipulates free drugs, diagnostics, food, and transport (to either home or higher facility) facility to the mother and her new-born. The time of participant recruitment and data collection was the period of post-partum stay at the facility. The data was collected minimum 12 hours after delivery to allow women to breastfeed, recover and rest before the interview. Because of the sensitivity of the study topic, the data was collected when women were alone in the post-partum ward to avoid bias (concealment of information) due to embarrassment in front of relatives/in-laws/spouse. This strategy was finalised after the pilot testing of the questionnaire. During the period of data collection, we enrolled all women coming for child-birth at the selected hospitals who fulfilled selection criteria for the study. The outcome variable was consumption of tobacco in any form for any duration by the women during the antenatal period. For the purpose of the study, we considered antenatal period as the time period between the date of woman's last menstrual period and date of delivery.
There were two sources of collected data. The first source was the participant's interview conducted using a pre-designed questionnaire, and the second source was the medical records relating to present pregnancy. To construct the questionnaire for the study, we conducted a systematic search on PubMed and Internet for the pre-validated questionnaire and relevant studies carried out in past on similar topic.,,,,,,, The study questionnaire had three parts – first part collected information on social demographic variables, second part collected information related to the knowledge of women about the adverse effects of tobacco and the third part collected data on antenatal history, obstetric care availed and pregnancy outcome. The information related to the obstetric care such as date of last menstrual period, date of urine pregnancy test and dates of all antenatal visits were collected from the medical records. In case a woman did not have any medical records or a woman's medical record was incomplete, in all such cases, the required/missing data was collected from the women herself. The questionnaire was translated from English to native language (Hindi). The questionnaire was pre-tested on 30 women admitted to post-partum ward of the district hospital of one of the selected three districts. The results of pre-test were excluded from the final data analysis. The final version of study questionnaire had a reliability of α =0.94. To be included in data analysis a woman needed to answer all the questions in the questionnaire.
The data collectors were nurses/ANM posted in the health facility. We trained three nurses/ANMs from each selected hospital. All data collectors from all facilities of a selected block were simultaneously trained for data collection, conducting an interview and providing health advice against tobacco and alcohol use. Due to the transfer of four data collectors (nurses) during the period of the study, we had to train new nurses for data collection. New data collectors were given onsite training during the routine visit (s) by the authors. Authors cross checked the quality of data collected by visiting health centres in a pre-decided sequence and providing on-site supervision to data collectors. Before collecting data, the consent form was given/read out to participants and data was collected only after obtaining the informed oral consent from the participants. After completion of the interview, all study participants irrespective of their tobacco consumption habit were given information about the hazards of tobacco and alcohol use with particular emphasis on restraining from tobacco and alcohol consumption during pregnancy. Those who consumed tobacco/alcohol during pregnancy were in addition given advice on quitting tobacco/alcohol. The present study was approved by ethical committee of the institute.
Filled questionnaire were checked for completeness of data and other errors before entering into the SPSS version 20.0 for analysis. Descriptive analyses were conducted to study the distribution of dependent variables among study participants. P value < 0.05 was considered statistically significant. Multivariate linear regression analysis was conducted to examine the relationship between the outcome and dependent variables. Adjusted odds ratios (AOR) and their 95% confidence intervals (CI) were used as to measure the strength of association.
| Results|| |
Data collectors approached a total of 4,280 women; 63 (1.5%) refused to participate in the study, 268 (6.3%) mother-newborn pair were referred out to higher health facility, questionnaire of 110 (2.6%) women were incomplete thus excluded, and hence, a total of 3,839 (89.7%) women were included in the final data analysis.
[Table 1] displays the background characteristics of the study participants according to their tobacco consumption habit. The mean age of the women who did and did not consume tobacco during pregnancy was 26.8 and 24.1 years, respectively. Husbands of most participants (both tobacco consumers and non-consumers) consumed tobacco in one form or the other. A higher proportion (63.4%) of women who consumed tobacco during pregnancy had a female family member who consumed tobacco as compared to women who did not consume tobacco during pregnancy (20.9%).
|Table 1: Distribution of biosocial characteristics of study participants by tobacco consumption habit during pregnancy (n=3,839)|
Click here to view
Perhaps the most significant findings of our study are detailed in [Table 2]. Most women (both tobacco consumers and non-consumers) were not aware of the harmful effects of tobacco consumption during pregnancy. Also, most women (both tobacco consumers and non-consumers) did not receive health advice in any form from frontline health workers (ANM and ASHA) about the harmful effects of tobacco consumption during pregnancy. Only 3.8% women who consumed tobacco and 3.9% women who did not consume tobacco were asked by physicians about tobacco consumption habit/history during the antenatal visits (all such women visited the same health center for antenatal care).
|Table 2: Distribution of study participants by tobacco consumption during pregnancy and antenatal care access (n=3,839)|
Click here to view
[Table 3] details the tobacco consumption pattern of study participants. The majority of women were consuming tobacco before they conceived, and only 5.6% of women started consuming tobacco (chewing) during present pregnancy. The most cited reason for tobacco initiation during pregnancy was the belief that tobacco helps in suppressing nausea associated with pregnancy (morning sickness). Most women were consuming tobacco for a period of 3–5 years and the majority of multiparous women had consumed tobacco during their previous pregnancy as well. Of all, 36.3% of women thought of quitting tobacco during pregnancy but only 17.9% of women attempted to quit tobacco by abstaining from its use.
|Table 3: Distribution of study participants by tobacco consumption pattern during pregnancy (n=503)|
Click here to view
[Table 4] details the result of multivariate analysis to identify the predictors of tobacco consumption during pregnancy. The strongest predictor of tobacco consumption during pregnancy were having a husband who consumes tobacco [AOR = 36.16 (CI = 22.89–68.86)] followed by having a female neighbor/friend who uses tobacco [AOR = 22.29 (CI = 13.11–31.82)], having female family member who consumes tobacco [AOR = 5.63 (CI = 4.39–7.53)]. Other predictors were rural background, living in a joint family and consuming alcohol during pregnancy.
|Table 4: Predictors of tobacco consumption during pregnancy; results of multivariate analysis|
Click here to view
| Discussion|| |
We observed that the prevalence of tobacco use in any form during pregnancy was 13.1%, which was higher than that reported by NFHS-3 survey for Madhya Pradesh (10.0%). However, prevalence observed in our study was lower than that reported by other studies conducted at Mumbai (24.7%) and Jharkhand (14.8%)., We observed that among tobacco consumers, only 1.6% smoked tobacco and rest 98.4% used smokeless tobacco. Our observations are supported by both NFHS-4 and NFHS-3 reports; both surveys reported that most women of Madhya Pradesh consumed tobacco in smokeless tobacco form., Many individual studies also support our finding that smokeless tobacco is the most popular form of tobacco consumption among Indian women.,,,
Most women in our study were already consuming tobacco before becoming pregnant, and most of them were consuming tobacco for a duration of 3–5 years. A study from Mumbai also reported that most women do not change their tobacco habit even if they become pregnant. Only 5.6% of women in our study initiated tobacco used uring pregnancy. The most common reason cited by such woman was that 'tobacco helped in countering symptoms of morning sickness' (53.6%). Thereafter, most such women continued using tobacco for the rest of the pregnancy even when symptoms of morning sickness subsided. Our findings are supported by two other studies which also reported that similar misconceptions are prevalent in other parts of India.,
Many women in our study consumed smokeless tobacco in more than one form (poly smokeless tobacco consumer). A study conducted at Mumbai also reported that 'poly-SLT' consumption is not uncommon among women. Such poly-SLT consumption probably indicates a high level of dependence among such women; they are probably compelled by their addiction to using any type of tobacco they can get their hands on to satisfy their need (s). It becomes essential to delineate the determinant of poly-SLT consumption because such women might be ingesting the higher amount of tobacco and thus may have a poor pregnancy, reproductive, oral and other health outcome (s) as compared to women who uses only one type of smokeless tobacco. We observed that pregnant women (both tobacco consumer and non-consumer) had very low level of awareness (12.3%) about the adverse effects caused by the use of tobacco during pregnancy. Three studies conducted in Jharkhand, Assam and Kolkata reported better awareness among pregnant women as compared to our study.,, This difference can be attributed to variation in the way study questions were framed, the type of tobacco in question and different geographical and socio-demographic (literacy levels) variables of study participants. Equally important was the observation that spouse (husband) of very few study participants (both tobacco consumer and non-consumer) advised pregnant women about adverse effects of tobacco consumption indicating that they (husband) themselves had a low level of awareness about the issue.
The government of India's guidelines for ANM, ASHA and physicians recommend that a pregnant woman should be asked about her tobacco consumption habit/history and should be advised appropriately., However, we observed that, of all women, only 4.4% women who consumed tobacco and 1.7% women who did not consume tobacco were informed by frontline health worker (ANM or ASHA) about ill effects of tobacco consumption during pregnancy. We observed that none of those women who initiated tobacco consumption during pregnancy (5.6%) received any health advice against tobacco use during pregnancy from either health workers or physicians. A Cochrane systematic review concluded that a variety of psychosocial interventions (including counselling) increases a woman's chance of stopping smoking during pregnancy and such interventions also reduced low birthweight and preterm births among pregnant women. Similar psychosocial interventions can also be developed for smokeless tobacco; ANM or primary care physician can be trained to provide such intervention (s) to support pregnant women quit tobacco. In our study, we observed that of all pregnant women; only 3.8% of those who consumed tobacco and 3.9% of those who did not consume tobacco were asked about tobacco consumption habits/history by a doctor during antenatal visits. We also observed that none of the prescription slips of antenatal visits that we collected data from had any mention of the tobacco consumption habit/history. Given the high prevalence of tobacco consumption among pregnant women in India, we need to sensitise the health care workforce to screen pregnant women who consume tobacco so that they can be educated about adverse effects of tobacco consumption.
In our study, we observed that more than one-third of all women thought of quitting tobacco during pregnancy and 17.9% tried unsuccessfully to quit tobacco by simply abstaining from its use. This shows the high unmet demand for quitting tobacco during pregnancy. Similar observations were also reported from other studies conducted in India and abroad.,, NFHS-4 also reported that about 29.3% (urban = 33.0%, rural = 28.2%) of all women who consumeed tobacco tried quitting tobacco use. A Cochrane systematic review concluded that nicotine replacement therapy (NRT) can be safely used in pregnancy and it increases smoking cessation rates by approximately 40%. Another Cochrane systematic review concluded that varenicline, nicotine lozenges and behavioural interventions may help smokeless tobacco users to quit. But before large scale implementation, we must verify the safety and effectiveness of these interventions among pregnant women. In conclusion, given the high prevalence of smokeless tobacco use among Indian women, we need to develop a set of tobacco cessation interventions (both pharmacological and non-pharmacological) for smokeless tobacco and integrate it with routine antenatal care so that all women, especially those who are motivated to give up tobacco can be helped.
In our study, about half of all pregnant women (irrespective of their tobacco consumption habit) were exposed to second-hand smoke. Similar observations were reported by many other studies conducted in different parts of India., In our study, most potent predictor of tobacco consumption among pregnant women was; tobacco consumption by closed one (husband, a female friend and family members). Thus, it is essential to involve a woman's husband and family member (s) in any health care intervention meant for preventing her from initiating/continuing tobacco use during pregnancy. It would be a good idea to create self-help group for supporting women to quit tobacco on the lines of groups meant for supporting breastfeeding. We observed that most commonly husband bought tobacco products for pregnant women followed by self- purchase. Similar findings were reported by the studies conducted at Mumbai and Jharkhand., These facts reiterate our earlier recommendation that any intervention (s) introduced to prevent women from initiating/continuing tobacco use during pregnancy must involve the unborn child's father.
We enrolled only those women who delivered at the hospital (s) and did not cover those women who gave birth at home. We did not verify the amount of tobacco consumed by women during their pregnancy nor did we assess the level of dependence by measuring biochemical parameters.
- The government of India needs to strengthen the implementation of its own guidelines for antenatal care.
- All pregnant women (regardless of their tobacco consumption habit) should be asked and advised against tobacco consumption during their first (if possible at every) antenatal visit because some women might start consuming tobacco after they become pregnant.
- Any intervention (s) program developed to prevent a woman from consuming tobacco during pregnancy must involve the husband.
- All family members should be sensitised not to expose pregnant women to second-hand smoke.
- The mass media campaign against tobacco should include advice against tobacco consumption during pregnancy.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
National Family Health Survey -4 (2016). India country factsheets. Indian Institute of Population Sciences, Mumbai. Government of India. Available from http://rchiips.org/NFHS/factsheet_NFHS-4.shtml
[Last Accessed on 2017 March 31].
National Family Health Survey -4 (2016). Madhya Pradesh factsheets. Indian Institute of Population Sciences, Mumbai. Government of India. Available from http://rchiips.org/NFHS/factsheet_NFHS-4.shtml
[Last Accessed on 2017 March 30].
U.S. Department of Health and Human Services. The Health Consequences of Smoking. 2004 Surgeon General's Report. U.S. Department of Health and Human Services, 2004.
Rogers JM. Tobacco and pregnancy. Reprod Toxicol 2009;28:152-60.
Salihu HM, Wilson RE. Epidemiology of prenatal smoking and perinatal outcomes. Early Hum Dev 2007;83:713-20.
Kramer MS. Determinants of low birth weight: Methodological assessment and meta-analysis. Bull World Health Organ 1987;65:663-737.
Kallen K. The impact of maternal smoking during pregnancy on delivery outcome. Eur J Public Health 2001;11:329-33.
Gupta PC. I140 Smokeless tobacco use in pregnancy:Adverse reproductive outcomes. Int J Gynecol Obstet 2012;119:S195.
Einarson A, Riordan S. Smoking in pregnancy and lactation: A review of risks and cessation strategies. Eur J Clin Pharmacol 2009;65:325-30.
Floyd RL, Belodoff B, Sidhu J, Schulkin J, Ebrahim SH, Sokol RJ. A survey of obstetrician–gynecologists on their patients' use of tobacco and other drugs during pregnancy. Prenatal and Neonatal Medicine 2001;6:201-7.
Graham H, Hawkins SS, Law C. Life course influences on women's smoking before, during and after pregnancy. Social Sci Med 2010;70:582-7.
Indian Public Health Standards for Primary Health Center -2012. Ministry of Health and Family Welfare. Government of India.
Singh S, Mini GK, Thankappan KR. Tobacco use during pregnancy in rural Jharkhand, India. Int J Gynecol Obstet 2015;131:170-3.
Pratinidhi A, Gandham S, Shrotri A, Patil A, Pardeshi S. Use of 'Mishri' A smokeless form of tobacco during pregnancy and its perinatal outcome. Indian J Community Med 2010;35:14-8.
] [Full text]
Ussher M, Etter JF, Giatras N, Coleman T. Tobacco withdrawal symptoms and urges to smoke in pregnant versus non-pregnant smokers. Addict Behav 2012;37:1353-7.
Nair S, Schensul JJ, Begum S, Pednekar MS, Oncken C, Bilgi SM, et al
. Use of Smokeless Tobacco by Indian Women Aged 18-40 Years during Pregnancy and Reproductive Years. PLoS One 2015;10:e0119814.
Gupta PC, Subramoney S. Smokeless tobacco use and risk of stillbirth: A cohort study in Mumbai, India. Epidemiology 2006;17:47-51.
Bloch M, Althabe F, Onyamboko M, Kaseba-Sata C, Castilla EE, Freire S, et al
. Tobacco use and secondhand smoke exposure during pregnancy: An investigative Survey of Women in 9 Developing Nations. Am J Public Health 2008;98:1833-40.
Bloch M, Parascandola M. Tobacco use in pregnancy: A window of opportunity for prevention. Lancet Glob Health 2014;2:e489-90.
Yang L, Tong EK, Mao Z, Hu T. Exposure to secondhand smoke and associated factors among non-smoking pregnant women with smoking husbands in Sichuan province, China. Acta Obstet Gynecol Scand 2010;89:549-57.
Sharma I, Sarma PS, Thankappan KR. Awareness, attitude and perceived barriers regarding implementation of the Cigarettes and Other Tobacco Products Act in Assam, India. Indian J Cancer 2010;47:63-8.
] [Full text]
Roychowdhury S, Roychowdhury G, Sen U. Assessment of awareness level on tobacco and smoking habits as risk factors for cancer among lung and laryngeal cancer patients in Kolkata-A case control study. Asian Pacific J Cancer Prev 2005;6:332-6.
Chamberlain C, O'Mara-Eves A, Oliver S, Caird JR, Perlen SM, Eades SJ, et al
. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database Syst Rev 2013;10:CD001055.
Ussher M, West R, Hibbs N. A survey of pregnant smokers' interest in different types of smoking cessation support. Patient Educ Couns 2004;54:67-72.
Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2015;12:CD010078.
Ebbert J, Montori VM, Erwin PJ, Stead LF. Interventions for smokeless tobacco use cessation. Cochrane Database Syst Rev 2011;2:CD004306.
[Table 1], [Table 2], [Table 3], [Table 4]